Presentations

17-May-2021	EXL 2021 AGM Recording

17-May-2021	2021 AGM - CEO Presentation

27-Apr-2021	Investor Presentation

18-Mar-2021	Special Investor Briefing: Proposed acquisition of CannaCare Health

16-Mar-2021	Investor Presentation: Proposed acquisition of CannaCare Health

27-Oct-2020	Q3 FY2020 Investor Briefing Video

27-Oct-2020	Investor Presentation

30-Sep-2020	Investor Presentation

30-Jul-2020	Elixinol AGM 2020

30-Jul-2020	2020 AGM - CEO Presentation

5-May-2020	Investor Presentation

27-Feb-2020	FY2019 Investor Results Presentation

27-Feb-2020	FY2019 Investor Results Presentation

29-Aug-2019	H1 FY2019 Results Presentation

23-May-2019	2019 AGM CEO Presentation

21-May-2019	Updated investor presentation May 2019

13-May-2019	Investor Presentation May 2019

13-Mar-2019	Investor Update March/April 2019

26-Feb-2019	FY 2018 Investor Results Presentation

31-Oct-2018	EXL Sydney Wholesale Investor Presentation

17-Oct-2018	EXL Aust Microcap Investment Conference Presentation

6-Sep-2018	EXL Presentation for Investor Briefings September 2018

29-Aug-2018	1H 2018 Investor Results Presentation

15-May-2018	2017 AGM Presentation

28-Feb-2018	FY2017 Investor Results Presentation

Contact

T: +61 2 4044 4585
E: info@elixinolglobal.com

Level 12, 680 George Street,
Sydney NSW 2000

PO Box 20547,
World Square NSW 2002
Australia